MARINUS PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.600 USD | +5.96% |
|
+15.11% | -85.28% |
| Aug. 14 | Ladenburg Thalmann Downgrades Marinus Pharmaceuticals to Neutral From Buy | MT |
| Aug. 13 | Marinus Pharmaceuticals, Inc., Q2 2024 Earnings Call, Aug 13, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 85.38M | - | - | - | |||
| 816B | ||||||
| 583B | ||||||
| 402B | ||||||
| 342B | ||||||
| 300B |
